Status:
COMPLETED
Real-life Prospective Evaluation of Computer-aided Detection (CAD) of Barrett's Neoplasia
Lead Sponsor:
Portsmouth Hospitals NHS Trust
Collaborating Sponsors:
St George's University Hospitals NHS Foundation Trust
Brighton and Sussex University Hospitals NHS Trust
Conditions:
Gastroscopy
Barrett's Esophagus
Eligibility:
All Genders
Brief Summary
Barrett's oesophagus is a pre-cancerous condition in which normal cells in the lining of gullet undergo cell changes and this increases the risk of developing adenocarcinoma (a type of cancer) of the ...
Detailed Description
Barrett's oesophagus is precursor to oesophageal adenocarcinoma and it affects 0.5-2% of the western population. It has 0.5-3% risk of yearly progression to cancer from which \<20% will survive at 5 y...
Eligibility Criteria
Inclusion
- Anyone aged 18 years and above
- Known Barrett's oesophagus and having a gastroscopy for Barrett's surveillance or assessment of known neoplasia.
- Participant is willing and able to give informed consent for participation in the study
Exclusion
- Recent ablation therapy (HALO, APC) to Barrett's oesophagus in the last 6 weeks
- Oesophageal disorder and patient's factors which impairs the ability of endoscopist to adequately assess of Barrett's neoplasia. This includes but not just limiting to severe oesophagitis, candidiasis, and poor patient tolerance.
Key Trial Info
Start Date :
July 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 27 2025
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT05965921
Start Date
July 26 2023
End Date
March 27 2025
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Alexandra Hospital, Portsmouth Hospitals University NHS trust
Portsmouth, Hampshire, United Kingdom, PO6 1LY